A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants
PHASE1
This study will assess the pharmacokinetics and relative Bioavailability of...
An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)
N/A
Crohn's Disease (CD) is a chronic condition that causes inflammation of the...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust /ID# 258989
Start Date
2023-10-26
Trial ID
NCT06126146
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants
PHASE1
This study will assess the pharmacokinetics and relative Bioavailability of...